Sugi Predict

Sugi Predict / Compounds / SCHEMBL15315231

SCHEMBL15315231

SCHEMBL15315231

CC1(C)CCC[C@@]2(C)[C@H]1CC[C@]1(C)OCC[C@@H]21

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ LTB4R Q15722 1/20 0.43
▸ ENTPD5 O75356 1/20 0.43
▸ PTPN1 P18031 3/20 0.41
▸ RPS6KA5 O75582 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.39
▸ IDO1 P14902 2/20 0.37
▸ NR1H4 Q96RI1 3/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ ALOX12 P18054 2/20 0.36
▸ TRPA1 O75762 1/20 0.35
▸ PTPN2 P17706 1/20 0.35
▸ HIF1A Q16665 1/20 0.34
▸ EPAS1 Q99814 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8410405 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL9016191 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL13455228 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL13455159 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL480931 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18129448 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL19924587 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL9201747 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL20672681 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14563524 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724593-A2 POLYPEPTIDES FOR PREPARING TERPENOID COMPOUNDS Firmenich SA (CH) 2026-04-15 — — EP disclosed
EP-4724592-A2 PREPARATION OF TERPENOID COMPOUNDS Firmenich SA (CH) 2026-04-15 — — EP disclosed
US-20250361536-A1 SQUALENE HOPENE CYCLASE (SHC) VARIANTS GIVAUDAN SA (CH) 2025-11-27 — — US disclosed
US-12416027-B2 Squalene hopene cyclase (SHC) variants GIVAUDAN SA (CH) 2025-09-16 — — US disclosed
WO-2024256472-A2 PREPARATION OF TERPENOID COMPOUNDS FIRMENICH SA (CH) 2024-12-19 — — WO disclosed
US-20240368647-A1 ENZYMES AND APPLICATIONS THEREOF PROTEUS SA (FR) 2024-11-07 — — US disclosed
US-12071645-B2 Enzymes and applications thereof GIVAUDAN SA (CH) 2024-08-27 — — US disclosed
US-20230357809-A1 SOLID FORM OF (-)-AMBROX FORMED BY A BIOCONVERSION OF HOMOFARNESOL IN THE PRESENCE OF A BIOCATALYST GIVAUDAN SA (CH) 2023-11-09 — — US disclosed
US-20230357809-A1 SOLID FORM OF (-)-AMBROX FORMED BY A BIOCONVERSION OF HOMOFARNESOL IN THE PRESENCE OF A BIOCATALYST GIVAUDAN SA (CH) 2023-11-09 — — US disclosed
US-11773419-B2 Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst GIVAUDAN SA (CH) 2023-10-03 — — US disclosed
US-20170029396-A1 PROCESS FOR THE PREPARATION OF (3E, 7E)-HOMOFARNESOL BASF SE (DE) 2017-02-02 — — US disclosed
US-9493385-B2 Process for the preparation of (3E, 7E)-homofarnesol BASF SE (DE) 2016-11-15 — — US disclosed
WO-2016170099-A1 ENZYMES AND APPLICATIONS THEREOF GIVAUDAN SA (CH) 2016-10-27 — — WO disclosed
WO-2016170099-A1 ENZYMES AND APPLICATIONS THEREOF GIVAUDAN SA (CH) 2016-10-27 — — WO disclosed
WO-2016170106-A1 PROCESS FOR ISOLATING AND PURIFYING AMBROX GIVAUDAN SA (CH) 2016-10-27 — — WO disclosed
EP-2838871-B1 METHOD FOR MANUFACTURING (3E, 7E) HOMOFARNESOL BASF SE (DE) 2016-08-10 — — EP disclosed
US-20160200648-A1 PROCESS FOR THE PREPARATION OF (3E, 7E)-HOMOFARNESOL BASF SE (DE) 2016-07-14 — — US disclosed
WO-2013156398-A1 IMPROVED PROCESS FOR PREPARING (3E,7E)-HOMOFARNESOL BASF SE (DE) 2013-10-24 — — WO disclosed
US-20130273619-A1 Process for the Preparation of (3E, 7E)-Homofarnesol BASF SE (DE) 2013-10-17 — — US disclosed
US-20130273619-A1 Process for the Preparation of (3E, 7E)-Homofarnesol BASF SE (DE) 2013-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368647-A1 ENZYMES AND APPLICATIONS THEREOF HAO1, HLCS, HACL2 ALDH1A1 1307/4885CYP3A4 1666/4885CYP2C9 992/4885
US-20230357809-A1 SOLID FORM OF (-)-AMBROX FORMED BY A BIOCONVERSION OF HOMOFARNESOL IN THE PRESENCE OF A BIOCATALYST CYP51A1, SQLE, BLVRB ALDH1A1 568/4885CYP3A4 10/4885CYP2C9 183/4885
US-20160200648-A1 PROCESS FOR THE PREPARATION OF (3E, 7E)-HOMOFARNESOL CYP8B1, CYP4F3, CYP2J2 ALDH1A1 241/4885CYP3A4 20/4885CYP2C9 38/4885
US-11773419-B2 Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst CYP51A1, SQLE, BLVRB ALDH1A1 568/4885CYP3A4 10/4885CYP2C9 183/4885
US-12071645-B2 Enzymes and applications thereof HAO1, HLCS, HACL2 ALDH1A1 1307/4885CYP3A4 1666/4885CYP2C9 992/4885
US-20170029396-A1 PROCESS FOR THE PREPARATION OF (3E, 7E)-HOMOFARNESOL CYP8B1, CYP4F3, CYP2J2 ALDH1A1 241/4885CYP3A4 20/4885CYP2C9 38/4885
US-20130273619-A1 Process for the Preparation of (3E, 7E)-Homofarnesol CYP8B1, CYP4F3, CYP2J2 ALDH1A1 241/4885CYP3A4 20/4885CYP2C9 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback